1994
DOI: 10.1016/0891-5849(94)90205-4
|View full text |Cite
|
Sign up to set email alerts
|

Ischemia-induced brain iron delocalization: Effect of iron chelators

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
31
0

Year Published

1996
1996
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 56 publications
(33 citation statements)
references
References 51 publications
2
31
0
Order By: Relevance
“…As in the case of the PD nigra, cerebral cortices and hippocampi affected by Alzheimer's disease and CNS tissues subjected to ischemidreperfusion exhibit enhanced glial HO-1 immunoreactivity, abnormal iron deposits, and mitochondrial insufficiency (Oubidar et al, 1994;Reichmann and Riederer, 1994;Schipper et al, 1995;Geddes et al, 1996;Janetzky et al, 1997). In addition, cytokines implicated in the pathogenesis of multiple sclerosis, such as tumor necrosis factor-a and interleukin-1 p, stimulate HO-1 expression in cultured astroglia followed by sequestration of non-transferrinderived iron by the mitochondrial compartment (K. Mehindate, S. Dion, and H. M. Schipper, unpublished results).…”
Section: Discussionmentioning
confidence: 99%
“…As in the case of the PD nigra, cerebral cortices and hippocampi affected by Alzheimer's disease and CNS tissues subjected to ischemidreperfusion exhibit enhanced glial HO-1 immunoreactivity, abnormal iron deposits, and mitochondrial insufficiency (Oubidar et al, 1994;Reichmann and Riederer, 1994;Schipper et al, 1995;Geddes et al, 1996;Janetzky et al, 1997). In addition, cytokines implicated in the pathogenesis of multiple sclerosis, such as tumor necrosis factor-a and interleukin-1 p, stimulate HO-1 expression in cultured astroglia followed by sequestration of non-transferrinderived iron by the mitochondrial compartment (K. Mehindate, S. Dion, and H. M. Schipper, unpublished results).…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, as a result of its high hydrosolubility, deferoxamine cannot rapidly reach the intracellular space of brain after acute systemic treatment (Lloyd et al, 1991). To our knowledge, whether liposoluble iron chelator can decrease histological damage induced by brain ischemia has never been reported; however, it was previously shown that the liposoluble iron chelator 2,2Ј-dipyridyl (DP) decreased edema induced by focal brain ischemia (Oubidar et al, 1994).…”
mentioning
confidence: 92%
“…Arguments exist for the existence of disruption of the cerebral iron homeostasis after ischemia. Thus, ischemic brain tissue was reported to accumulate ultrafiltrable iron (Oubidar et al, 1994;Lipscomb et al, 1998) and to express a high level of ferritin (Chi et al, 2000), an indirect marker of free iron excess. Indeed, the main mechanism elaborated by cells to keep the intracellular free iron level within normal range is the regulation by free iron level itself of the synthesis of ferritin (Eisenstein, 2000), the main intracellular iron storage protein.…”
mentioning
confidence: 99%
“…In hypoxia and reoxygenation-mediated neuronal injury, an important role is ascribed to the ionized iron, which may participate in Fenton-type reactions and thus catalyze the generation of reactive oxygen species (Oubidar et al, 1994). Deferoxamine mesylate chelates ionized iron in Fe 3+ state (Halliwell & Gutteridge, 1999), thus making it unavailable for catalytic action in a Fenton type reaction.…”
Section: Discussionmentioning
confidence: 99%